Background and Purpose-Here, we assessed how sustained is reversal of the acute diffusion lesion (RAD) observed 24 hours after intravenous thrombolysis, and the relationships between RAD fate and early neurological improvement. Methods-We analyzed 155 consecutive patients thrombolyzed intravenously 152 minutes (median) after stroke onset and who underwent 3 MR sessions: 1 before and 2 after treatment (median times from onset, 25.6 and 54.3 hours, respectively).
A ll current MR-based approaches in candidates for reperfusion therapy depend on diffusion-weighted imaging (DWI) for an accurate assessment of infarct core. DWI is necessary not only to map the perfusion weighted imaging-DWI mismatch but also in relation to lesion volume cut-offs above which thrombolysis may not have clinical benefit or be even harmful. However, the widely prevalent model that at early time points, the DWI lesion exclusively represents the infarct core has been a matter of controversy. Both early animal research [1] [2] [3] and recent clinical studies [4] [5] [6] [7] [8] have reported that DWI lesions can reverse either spontaneously or after recanalization, suggesting that they contain not only core but also some penumbral tissue. Thus, DWI lesion reversal has been reported in one third of patients after recanalization therapy 9 and in up to one half after intravenous thrombolysis. 6 In the latter population, DWI lesion reversal at 24 hours was associated with early neurological improvement (ENI) in a dose-dependent manner, 6 and with favorable clinical outcome at hospital discharge in another study, 8 supporting the notion that early reperfusion and its impact on the 24-hour DWI lesion are potential markers of therapeutic efficacy and favorable outcome.
One could however argue that when assessed 24 hours after therapy, DWI lesion reversal may be largely transient and regularly followed by secondary injury. Effectively, both transient and sustained DWI reversal have been reported in experimental and clinical stroke. 3, [9] [10] [11] [12] [13] [14] [15] The fact that early reperfusion mediates DWI reversibility in experimental 3,10-13 and human stroke 7, 8, [16] [17] [18] could explain why sustained DWI reversal is rather uncommon when treatment is administered in delayed timeframes, 9, 19, 20 whereas being common and sizeable when treatment is given at earlier time points. 6, 8, 18 However, the full temporal profile of this phenomenon remains largely unknown, especially after intravenous thrombolysis.
Taking together the above data, we make the hypothesis that most of the DWI lesion reversal observed 24 hours after intravenous thrombolysis administered ≤4.5 hours from onset will be sustained on follow-up MR. We further predict that sustained, but not transient, DWI lesion reversal is associated with ENI and has less impaired baseline apparent diffusion coefficient (ADC) and perfusion. To test these hypotheses, we assessed voxel-wise the fate of early DWI lesion reversal, namely transient or sustained, in a series of patients with acute stroke imaged before, on the following day, and 2 to 7 days after intravenous thrombolysis, and their respective relationships with ENI.
Materials and Methods

Patients
This was a retrospective analysis based on a prospectively collected registry of patients treated by intravenous thrombolysis for ischemic stroke from January 2009 to December 2013. The study was approved by the local ethics committee. In our center, MR examinations are scheduled at 3 time points: before treatment as first-line diagnostic tool (MR 1 ), on the following day (to assess the arterial recanalization status, and search for complications; MR 2 ) and at 48 to 72 hours (MR 3 ) for pathogenic work-up (cervical MR angiography), and final infarct assessment (DWI only). Here, we included all patients who fulfilled the following inclusion criteria: (1) final diagnosis of ischemic stroke; (2) treated exclusively with intravenous tissue-type plasminogen activator; (3) who underwent the 3 aforementioned MR exams within 7 days after stroke onset; and (4) without severe DWI artifacts.
We prospectively recorded demographic details, stroke onsetto-MRI and onset-to-treatment times, National Institutes of Health Stroke Scale at admission and 24 hours, blood pressures, serum glucose, stroke arterial distribution, and hemorrhagic transformation on MR 2 according to the European Cooperative Acute Stroke Study classification criteria from the T2* sequence. Pretreatment occlusion was categorized into proximal (carotid, basilar artery, or proximal postWillisian segment) and distal or no occlusion. Twenty-hour recanalization was defined as thrombolysis in cerebral infarction criteria ≥2 on MR 2 angiography. ENI was defined as a gain of National Institutes of Health Stroke Scale ≥8 within the first 24 hours, or National Institutes of Health Stroke Scale ≤1 at 24 hours. 21, 22 Modified Rankin Scale was assessed at 3 months. 1 ) and follow-up (DWI 2 and DWI 3 ) coregistered images, acquired 100 minutes, 24 hours, and 40 hours after stroke onset, respectively, in this patient. RAD represents DWI 1 voxels not overlapping with DWI 2 voxels. sRAD (green) are RAD voxels not overlapping with the coregistered lesion on DWI 3 , and tRAD voxels (yellow) are those overlapping with the DWI 3 lesion. Unchanged voxels are hyperintense on all 3 DWI lesions (red).
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MR Protocol
All MR examinations were performed on a 1.5-T scanner (GE Healthcare). For MR 1 and MR 2 , the protocol included fluid-attentuated inversion recovery, DWI, T2*, intracranial MR angiography. 23 First-pass gadolinium T2*-weighted echo-planar perfusion weighted imaging (EPI) was performed before treatment decision whenever feasible with no delay. A T2-weighted baseline image (b=0 s/mm 2 ) and the DWI (b=1000 s/mm 2 ) were acquired with a single-shot EPI spin-echo sequence with the following parameters: 6675/81 to 104 (repetition time/echo time range, ms), 24×24-cm 2 field of view, 128×128 matrix, 2 excitations, 24 sections, 6-mm thick, no gap, 53 s. Perfusion weighted imaging data were postprocessed using BrainStat arterial input function (READY View, Advantage Workstation; GE Healthcare) software for an automated generation of time-to-maximum (T max ) maps. 
Image Analysis
Coregistration and segmentation. MR 2 and MR 3 images were coregistered to MR 1 using an automated 3-dimensional rigid registration with FSL software-FLIRT (Oxford, England), visually checked then manually corrected whenever necessary. DWI 1 , DWI 2 , and DWI 3 lesions were manually segmented using MANGO software version 3.0.4. Regions of interest were drawn using a combination of interactive thresholding and drawing tools. The segmented DWI voxels were projected onto apparent ADC maps to exclude areas of T2 shinethrough effects and include areas of decreased ADC with subtle DWI signal changes. Hemorrhagic transformations were manually included in the segmentation of DWI 2 and DWI 3 to avoid overestimating any reversal of the DWI lesions.
DWI lesion reversal. Reversible acute DWI (RAD) voxels were defined as those DWI 1 voxels that did not overlap with the coregistered lesion on DWI 2 . 6, 24 To assess the fate of RAD voxels, we distinguished sustained RAD (sRAD) defined as RAD voxels that did not overlap with the DWI 3 lesion and transient RAD (tRAD) defined as RAD voxels that overlapped with the DWI 3 lesion. The unchanged area corresponded to voxels that were hyperintense in all 3 DWI scans ( Figure 1 ). To rule out the possibility that the DWI 3 signal had normalized while corresponding T2-changes appeared, we visually checked Unless specified, all numbers are median (interquartile range). %sRAD indicates sRAD voxels/pooled RAD voxels×100; DWI, diffusion-weighted imaging; RAD, reversible acute DWI lesion; and sRAD, sustained RAD.
*Median volume in the whole population. Figure 2 . Sustained diffusion-weighted imaging (DWI) reversal. DWI 1 showed a hyperintense lesion in the left middle cerebral artery territory in this patient presenting with right hemiparesis and dysphasia (National Institutes of Health Stroke Scale [NIHSS]=12). After thrombolysis, the whole DWI lesion reversal observed on DWI 2 was sustained on DWI 3 , without corresponding signal changes on T2-weighted images. The 24-hour NIHSS was 0.
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http://stroke.ahajournals.org/ Downloaded from that sRADs were not hyperintense on T2-EPI, and that T2-EPI signal changes differed between sRAD and unchanged areas on the last MR. We then computed the %sRAD (volume of sRAD/RAD×100) in the whole population and in subgroups of patients with sizeable RAD using 3 definitions (Table 1) . These subgroup analyses were performed to rule out potential measurements errors linked to small RAD volumes. 6 For the same reasons, baseline ADC and T max in sRAD, tRAD and unchanged 3-dimensional regions of interests were computed only for the 50% of patients with RAD volume above the median value.
Statistical Analysis
Continuous variables were described as mean±SD or median and interquartile range, and compared with Student t test or Mann-Whitney U test, as appropriate. Categorical variables were compared using χ2 or Fisher exact test as appropriate. To test our hypothesis that sRAD volume may be a correlate for clinical outcome, we first conducted a univariate analysis comparing clinical and imaging variables between patients with and without ENI. In a multivariate analysis using a backward selection method (entry for P<0. 20) , we then tested the association of sRAD volume and ENI (MedCalc, 13.3.3.0; Mariakerke, Belgium).
Results
Patients
During the study period, 354 patients underwent intravenous thrombolysis for an ischemic stroke in our center, of which 199 (56.2%) were excluded because of bridging therapy (n=54), use of computed tomography instead of MR 1 (n=38) or MR 2 (n=28), lack of MR 3 (n=52) or DWI 3 (n=7), MR 3 obtained >7 days (n=12), severe artifacts on DWI (n=5) or death before follow-up MR (n=3). Excluded patients did not differ from the included patients in age or onset-to-treatment time but had higher baseline National Institutes of Health Stroke Scale (median [interquartile range], 14 [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] 
sRAD Versus tRAD
Across the whole sample, median (interquartile range) RAD volume at MR 2 was 2.8 (1.1-6.6) mL and >5 and 10 mL in 54 (34.8%) and 23 (14.8%) patients, respectively. As shown in Table 1 , median sRAD represented 70.8% (51.6%-88.2%) of the pooled RAD voxels, and >80% of the pooled voxels belonging to sizeable RAD, regardless of the definition. Similar results were obtained when analysis was conducted per-patient rather than on pooled RAD voxels (data not shown). Sixteen (10.3%) patients had sRAD ≥10 mL, and in 20 patients (12.9%) sRAD involved more than half of the baseline DWI 1 lesion. On the last MR, no sRAD areas were hyperintense on T2-EPI, and signal changes on T2-EPI were significantly lower in sRAD than in infarct core (P<0.0001; Figure 2 ).
In the subset of patients with RAD volume above the median value (ie, 2.8 mL), baseline T max (available in 51 [65.4%] patients) was significantly less impaired in sRAD than in tRAD, and in tRAD than in the unchanged area. sRAD showed a nonsignificant trend (P=0.08) for higher baseline ADC than tRAD, and both sRAD and tRAD had higher ADC than the unchanged area (Table I in the online-only Data Supplement). These results were not substantially different Unless specified, numbers are median (interquartile range). BP indicates blood pressure; DWI, diffusion-weighted imaging; ENI, early neurological improvement; mRS, modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; and RAD, reversible acute DWI lesion.
*Data missing or not assessable in 10 patients. Missing data for †12 and ‡9 patients.
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using alternative definitions of sizeable RAD (eg, >5 or 10 mL; data not shown).
Relationships Between sRAD and Clinical Outcome
Fifty-three (34.2%) patients experienced ENI 24 hours after thrombolysis. Patients with ENI had significantly lower serum glucose level and shorter onset-to-treatment time, higher rate of recanalization, and greater RAD volume than non-ENI patients (Table 2) . Furthermore, patients with ENI also had greater %sRAD and larger sRAD volumes but similar tRAD volumes. In multivariate analysis, sRAD volume and recanalization were significantly associated with ENI (Table 3) .
Discussion
Addressing the time course of DWI lesion reversal in a sample of thrombolyzed patients, we showed that the reversibility observed at 24 hours was sustained at the final MR session in over two third of RAD voxels. As predicted, only sustained reversibility was associated with ENI, independently of other relevant variables. Finally, initial hypoperfusion was, as also predicted, worse for tRAD voxels. These findings shed new light on the currently debated issues around transient versus sustained DWI lesions after thrombolysis. That most of the DWI lesion reversal observed at 24 hours exhibits sustained tissue salvage in the early thrombolysis time window is not unexpected. Indeed, early reperfusion is of utmost importance for sustained tissue salvage, with studies demonstrating permanent normalization of parts or all of the initial DWI lesion after short periods of occlusion. 7, 18, 25, 26 For instance, in rodents, resolution of DWI lesions is sustained after short, but transient after longlasting occlusions. 3, 13 The established relationship between early recanalization and sustained lesion reversibility 3, 26, 27 partly explains why reversibility is often transient in patients treated in later time windows. 9, 19, 20, 28 Differences between studies on the outcome of DWI reversibility may also be explained by heterogeneity in imaging protocol. 18 The timing of follow-up MRI is indeed essential when evaluating DWI lesion reversal. In rats with prolonged occlusion, the ADC decreases significantly during occlusion, recovers completely at 60 minutes after reperfusion, but declines secondarily at 12 hours after reperfusion. 3 Thus, transient DWI lesion reversal occurs rapidly after reperfusion and would only be captured if follow-up MR is scheduled soon after treatment. Indeed, prominent transient DWI lesion reversal has been observed when the first follow-up MR was scheduled soon (<12 hours) after treatment. 9, 18, 20 Conversely, 24-hour follow-up MR likely misses most of this temporary postreperfusion reversal because images are acquired beyond the time of transient ADC pseudonormalization. This in turn explains why most of the DWI lesion reversal that we observed on 24 hours MR was sustained, in line with a recent study on patients with minor to moderately severe stroke, 20% of whom received intravenous tissue-type plasminogen activator, that found 87% of the DWI lesion reversal on 24-hour MRI to be sustained at 4 to 7 days. 15 On a pathophysiological standpoint, sRAD voxels were initially less severely hypoperfused than their transient counterparts, in line with our initial hypothesis. Our T max data suggest that perfusion could help distinguish true core from the penumbral portion of the acute DWI lesion.
The clinical implications of DWI lesion reversal and of its sustained versus transient compartments remain debated. 28 The phenomenon of transient lesion reversal has been speculated to reflect salvage followed by secondary injury. 20 However, the expected clinical correlate of improvement followed by deterioration has never been observed in this scenario. 18, 28 Moreover, transient reversibility seems unrelated to ENI in patients treated in the early time window as shown here, congruent with findings in the later time windows. 9, 19 This lack of clinical correlate suggests that the transient pseudonormalization of DWI signal does not indicate full tissue recovery from ischemic injury, in line with animal studies. 3 Thus, there may be an apparent DWI reversibility (tRAD), which is transient because the underlying tissue is damaged early after the ischemic insult, and a real reversibility (sRAD), which corresponds to salvaged penumbra, and hence has clinical correlates.
We found sizeable sRAD in 10% of patients, involving >50% of the initial DWI lesion in 12.9%, indicating that although large sustained DWI lesion reversal is not common, it is not negligible either in the early timeframe. These findings mirror the rate and extent of sRAD observed in 60 patients from the 3-to 6-hour window Diffusion Weighted Imaging Evaluation for Understanding Stroke Evolution Study-2 (DEFUSE 2), 9 namely >10 mL in 17% patients. In DEFUSE, spontaneously reperfused DWI lesions before thrombolysis had the highest rate of sustained DWI reversal, and the latter was associated with clinical recovery. 7 Here, we found that the volume of sustained, but not that of transient, DWI lesion reversal was strongly associated with ENI. This finding reinforces the notion that sustained reversibility after thrombolysis is not an epiphenomenon and that it does have meaningful clinical correlates. That the sRAD volume is a correlate of ENI does not however imply that it alone accounts for the latter. Although ENI largely derives from concomitant reperfusion of adjacent mismatch regions, it may in part result from reperfusion of the The use of multimodal MR in evaluating efficacy of thrombolytic therapy has been recently emphasized in a study showing that early reperfusion at 2 hours and decrease in DWI lesion volume at 24 hours were independent predictors of favorable outcome. 8 Another study also found dramatic improvement to be more common in patients with early DWI lesion reduction after intravenous thrombolysis. 18 Note however that both studies were based on DWI lesion volume subtraction, as compared with voxel-wise here. That the 24-hour reversibility was largely sustained using serial coregistered MRIs here strengthens the notion that 24-hour follow-up MR affords a reasonable estimate of sustained DWI lesion reversibility, itself a surrogate for early recanalization and ENI after thrombolysis. 8 Our study has several limitations. First, that 3 MR examinations were required likely explains why eligible patients had less severe strokes. This may have biased our results toward favorable outcome and caused some overestimation of the RAD phenomenon. However, the volumes of total RAD and sRAD were in the previously reported ranges. 6, 9, 19 Second, the timing of MR 3 was variable and delayed changes might have been missed, especially if MR 3 was performed too early. However, post hoc analyses showed that patients whose MR 3 was the earliest (ie, lower onsetto-MR 3 time quartile) exhibited a similar %sRAD than those with latest MR 3 (ie, upper quartile) (75.5% [57.5%-90.5%] versus 69.0% [57.0%-90.0%]; P=0.79). Although the timing of MR 3 minimized the confounding effect of vasogenic edema, a rim of edema may nevertheless develop early in large lesions and lead to overestimation of the final lesion. This would in turn have led to an underestimation of sRAD and if anything weakened our main findings. Finally, a normal DWI signal does not exclude the presence of subtle histological changes undetectable on standard MRI sequences. 3, 13, 30 In summary, we showed that most of the diffusion lesion reversibility captured on 24-hour imaging is effectively sustained at later MR scans, and that sustained reversal is an imaging correlate of ENI. This strengthens the notion that 24-hour MR follow-up affords a reasonable estimate of sustained DWI lesion reversibility, itself an imaging correlate of early recanalization after thrombolysis. 8 
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